Correlation Between Emergent Biosolutions and Artelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Artelo Biosciences, you can compare the effects of market volatilities on Emergent Biosolutions and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Artelo Biosciences.

Diversification Opportunities for Emergent Biosolutions and Artelo Biosciences

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Emergent and Artelo is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Artelo Biosciences

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 1.96 times more return on investment than Artelo Biosciences. However, Emergent Biosolutions is 1.96 times more volatile than Artelo Biosciences. It trades about 0.03 of its potential returns per unit of risk. Artelo Biosciences is currently generating about -0.03 per unit of risk. If you would invest  1,181  in Emergent Biosolutions on September 20, 2024 and sell it today you would lose (365.00) from holding Emergent Biosolutions or give up 30.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Emergent Biosolutions  vs.  Artelo Biosciences

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Emergent Biosolutions and Artelo Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and Artelo Biosciences

The main advantage of trading using opposite Emergent Biosolutions and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.
The idea behind Emergent Biosolutions and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites